Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127677492 | 12767749 | 2 | F | 20160904 | 20160923 | 20160921 | 20160928 | EXP | US-ACTELION-A-US2016-142624 | ACTELION | 64.00 | YR | A | F | Y | 0.00000 | 20160928 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127677492 | 12767749 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 5 MCG, 6-9X DAY | MA02DL0 | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION | ||||||
| 127677492 | 12767749 | 2 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | UNK, 6X/DAY | 21779 | INHALATION VAPOUR, SOLUTION | |||||||||
| 127677492 | 12767749 | 3 | C | ADCIRCA | TADALAFIL | 1 | 40 MG, QD | U | 0 | 40 | MG | QD | |||||||
| 127677492 | 12767749 | 4 | C | WARFARIN | WARFARIN | 1 | 7.5 MG, QD | U | 0 | 7.5 | MG | QD | |||||||
| 127677492 | 12767749 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 125 MCG, QD | U | 0 | 125 | UG | QD | |||||||
| 127677492 | 12767749 | 6 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 2 PUFF, BID | U | 0 | BID | |||||||||
| 127677492 | 12767749 | 7 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 20 MEQ, QD | U | 0 | 20 | MEQ | QD | |||||||
| 127677492 | 12767749 | 8 | C | LASIX | FUROSEMIDE | 1 | 80 MG, Q4WEEK | U | 0 | 80 | MG | ||||||||
| 127677492 | 12767749 | 9 | C | LASIX | FUROSEMIDE | 1 | 40 MG, Q3WEEK | U | 0 | 40 | MG | Q3W | |||||||
| 127677492 | 12767749 | 10 | C | DILTIAZEM. | DILTIAZEM | 1 | 120 MG, QD | U | 0 | 120 | MG | QD | |||||||
| 127677492 | 12767749 | 11 | C | CALCIUM | CALCIUM | 1 | 600 MG, QD | U | 0 | 600 | MG | QD | |||||||
| 127677492 | 12767749 | 12 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 40 MG, QD | U | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127677492 | 12767749 | 1 | Pulmonary hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127677492 | 12767749 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127677492 | 12767749 | Fall | |
| 127677492 | 12767749 | Subdural haematoma | |
| 127677492 | 12767749 | Subdural haematoma evacuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127677492 | 12767749 | 1 | 20150316 | 0 |